Union Hospital Of Tongji Medical College News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Union hospital of tongji medical college. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Union Hospital Of Tongji Medical College Today - Breaking & Trending Today

Lung abnormalities persist in some patients 2 years after COVID-19 infection

Thirty-nine percent of patients who suffered a COVID-19 infection had interstitial lung abnormalities 2 years following the illness, according to study results published in Radiology.“At 2-year follow-up, interstitial lung abnormalities (ILAs) or fibrotic ILAs were associated with persistent respiratory symptoms and decreased diffusion function,” Xiaoyu Han, MD, PhD, of the department ....

Xiaoyu Han , Union Hospital Of Tongji Medical College , Union Hospital , Tongji Medical College ,

Christian Drosten and the 'Bat Woman' of Wuhan

Commentary Thanks to an observant Twitter user (hat-tip @lissnup), I now know much more about the curious photo of . ....

Yangtze River , China General , Yang Dongliang , Christian Drosten , Shi Zhengli , Ulf Dittmer , Brownstone Institute , Union Hospital Of Tongji Medical College , Essen University Hospital , University Hospital , University Of Duisburg , Mother Lab , Tongji Medical College , German Ministry Of Health , Wuhan Institute Of Virology , German Symposium , Wuhan Institute , Wayback Machine , German Ministry , Tongji Medical , Unlike Shi Zhengli , Animal Reservoirs , Emergent Viral Zoonoses , Special Emphasis , Treatment Possibilities , Union Hospital ,

Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to. ....

Hong Kong , South Korea , Jun Ma , Jianxiang Wang , Jay Mei , Asia Pacific , Peter Qian , Xiaojun Huang , Depei Wu , Company Annual , Antengene Corporation , National Cancer Care Network , European Society Of Medical Oncology , Shanghai Pharmaceutical Co Ltd , China National Medical Products Administration , Health Commerce Co Ltd , Sinopharm Distribution Co Ltd , Harbin Institute Of Hematology Oncology , Huazhong University Of Science , Karyopharm Therapeutics Inc , Drug Administration , Union Hospital Of Tongji Medical College , University People Hospital , Gang Special Area Co Ltd , China Resources Hunan Ruige Pharmaceutical Co Ltd , Pharmacy Franchise Co Ltd ,

Alphagalileo > Item Display

Price:
Scientists atSt. JudeChildren’s Research Hospital are working with colleagues in China to develop better therapy for childhood acute lymphoblastic leukemia (ALL). Results from a large phase 3 noninferiority clinical trial definitively showed that vincristine and dexamethasone pulses can be eliminated in patients with low-risk disease. The findings were published today in
The
Lancet Oncology.
Adding the chemotherapy vincristine plus a steroid (originally prednisone, and later dexamethasone) as pulse therapy for childhood ALL has been part of standard care since the 1970s. This is despite their being associated with neuropsychological side effects, neuropathy and other late effects. However, to date studies about the need for prolonged treatment with pulse therapy have been inconclusive. ....

Hong Kong , Hua Jiang , University Of Hong Kong , Hong Kong General , Hui Jiang , Hui Zhang , Jing Chen , Jingyan Tang , Aiguo Liu , Ju Gao , Yingchi Zhang , Wenyu Yang , Changda Liang , Minghua Yang , Kaili Pan , Runming Jin , Yongjun Fang , Chunfu Li , Yiping Zhu , Lirong Sun , Junj Yang , Jiaoyang Cai , Jie Yu , Xuedong Wu , Xiaowen Zhai , Ningling Wang ,